---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286452523.md"
description: "ClearPoint Neuro shares are trading higher after the company reported better-than-expected Q1 sales results and reaffirmed its FY26 sales guidance with its midpoint above estimates."
datetime: "2026-05-14T17:16:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286452523.md)
  - [en](https://longbridge.com/en/news/286452523.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286452523.md)
---

# 

ClearPoint Neuro shares are trading higher after the company reported better-than-expected Q1 sales results and reaffirmed its FY26 sales guidance with its midpoint above estimates.

### Related Stocks

- [CLPT.US](https://longbridge.com/en/quote/CLPT.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Pharma giants commit $500B to US amid tariff threat](https://longbridge.com/en/news/289866895.md)
- [The wrong prescription for drug affordability](https://longbridge.com/en/news/289929515.md)
- [Lake Street Keeps Their Buy Rating on ClearPoint Neuro (CLPT)](https://longbridge.com/en/news/288440870.md)
- [ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software](https://longbridge.com/en/news/273537947.md)